Container
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
The variation of tonality in the drawings depicts a claimed contrasting appearance.
The broken line portion of the figure drawings is included to show unclaimed subject matter only and forms no part of the claimed design.
Claims
The ornamental design for a container, as shown and described.
D245762 | September 13, 1977 | Takacs |
D292626 | November 3, 1987 | Chevassus |
D365206 | December 19, 1995 | Goodman |
D373952 | September 24, 1996 | Exarhos et al. |
D406233 | March 2, 1999 | Kaplan |
D458127 | June 4, 2002 | de Groote |
D516801 | March 14, 2006 | Jones et al. |
D546671 | July 17, 2007 | Cronin et al. |
D623052 | September 7, 2010 | Giraud et al. |
Type: Grant
Filed: Apr 18, 2013
Date of Patent: Mar 25, 2014
Assignee: Glaxo Group Limited (Brentford, Middlesex)
Inventors: Stuart John Farley (Ware), Andrew Michael Kelly (Letchworth)
Primary Examiner: Thomas Johannes
Application Number: 29/452,572